Before You Begin
Question #45187
The Question
A foreign multinational company utilizes indigenous Indian livestock germplasm without authorization to develop a transgenic animal. This animal is engineered to produce a specific recombinant human protein used for the treatment of emphysema. The company then successfully patents this biological process. Which of the following statements regarding this scenario and related biotechnological applications is INCORRECT?
Options
- A.
The specific recombinant human protein produced by the transgenic animal for treating emphysema is alpha-1-antitrypsin.
- B.
The unauthorized use and patenting of the indigenous livestock germplasm by the multinational company constitutes biopiracy.
- C.
In India, the Genetic Engineering Appraisal Committee (GEAC) is responsible for making decisions regarding the validity of such GM research.
- D.
Similar to this therapeutic approach, the first transgenic cow, Rosie, was engineered to produce alpha-1-antitrypsin enriched milk (2.4 grams per litre).
Check Your Answer
Correct Answer
Step-by-Step Solution
Explanation
How the Examiner Thinks
Regulatory_Failure
Understand how NOT, EXCEPT, and logical constraints are used to manipulate exam results.
Concepts Behind This Question
Cry protein|Thermal Tolerance Ranges|Ecological Succession Climax
Why This Question Is Tricky
Common Mistakes
Conceptual Pivot: Misattribution of transgenic products.
Students frequently memorize the names of transgenic animals (Rosie) and recombinant proteins (alpha-1-antitrypsin) but mix up their specific associations.
The trap relies on Functional Overlap, confusing the nutritional protein (alpha-lactalbumin) produced by Rosie with the therapeutic protein (alpha-1-antitrypsin) used for emphysema.
Quick Facts About This Question
Question Information
| Subject | Biology |
| Chapter | Biotechnology and Its Applications - Class 12 |
| Concept | Cry Gene Specificity |
| Difficulty | 8 |
| Cognitive Load | 5 |
| Target Solve Time | 120 sec |
| Access | Free |